308 related articles for article (PubMed ID: 25336032)
1. HBsAg-negative hepatitis B virus infection and hepatocellular carcinoma.
Chen L; Zhao H; Yang X; Gao JY; Cheng J
Discov Med; 2014 Oct; 18(99):189-93. PubMed ID: 25336032
[TBL] [Abstract][Full Text] [Related]
2. Hepatitis B virus (HBV) DNA integration in patients with occult HBV infection and hepatocellular carcinoma.
Saitta C; Tripodi G; Barbera A; Bertuccio A; Smedile A; Ciancio A; Raffa G; Sangiovanni A; Navarra G; Raimondo G; Pollicino T
Liver Int; 2015 Oct; 35(10):2311-7. PubMed ID: 25677098
[TBL] [Abstract][Full Text] [Related]
3. Molecular and serological aspects of HBsAg-negative hepatitis B virus infections in North America.
Hsia CC; Scudamore CH; Di Bisceglie AM; Tabor E
J Med Virol; 2003 May; 70(1):20-6. PubMed ID: 12629639
[TBL] [Abstract][Full Text] [Related]
4. Role of occult hepatitis B virus infection in chronic hepatitis C.
Coppola N; Onorato L; Pisaturo M; Macera M; Sagnelli C; Martini S; Sagnelli E
World J Gastroenterol; 2015 Nov; 21(42):11931-40. PubMed ID: 26576082
[TBL] [Abstract][Full Text] [Related]
5. Clinical features of HBsAg-negative but anti-HBc-positive hepatocellular carcinoma in a hepatitis B virus endemic area.
Shim J; Kim BH; Kim NH; Dong SH; Kim HJ; Chang YW; Lee JI; Chang R
J Gastroenterol Hepatol; 2005 May; 20(5):746-51. PubMed ID: 15853989
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological study of occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma.
El-Maksoud MA; Habeeb MR; Ghazy HF; Nomir MM; Elalfy H; Abed S; Zaki MES
Eur J Gastroenterol Hepatol; 2019 Jun; 31(6):716-722. PubMed ID: 30870221
[TBL] [Abstract][Full Text] [Related]
7. The intracellular HBV DNAs as novel and sensitive biomarkers for the clinical diagnosis of occult HBV infection in HBeAg negative hepatocellular carcinoma in China.
Wang H; Fang M; Gu X; Ji Q; Li D; Cheng SQ; Shen F; Gao CF
PLoS One; 2014; 9(9):e107162. PubMed ID: 25229710
[TBL] [Abstract][Full Text] [Related]
8. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
9. Occult HBV infection in Morocco: from chronic hepatitis to hepatocellular carcinoma.
Kitab B; Ezzikouri S; Alaoui R; Nadir S; Badre W; Trepo C; Chemin I; Benjelloun S
Liver Int; 2014 Jul; 34(6):e144-50. PubMed ID: 24502524
[TBL] [Abstract][Full Text] [Related]
10. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
11. Among Patients with Undetectable Hepatitis B Surface Antigen and Hepatocellular Carcinoma, a High Proportion Has Integration of HBV DNA into Hepatocyte DNA and No Cirrhosis.
Wong DK; Cheng SCY; Mak LL; To EW; Lo RC; Cheung TT; Seto WK; Fung J; Man K; Lai CL; Yuen MF
Clin Gastroenterol Hepatol; 2020 Feb; 18(2):449-456. PubMed ID: 31252193
[TBL] [Abstract][Full Text] [Related]
12. Impact of occult hepatitis B virus infection on the outcome of chronic hepatitis C.
Squadrito G; Cacciola I; Alibrandi A; Pollicino T; Raimondo G
J Hepatol; 2013 Oct; 59(4):696-700. PubMed ID: 23751755
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of children with postnatal immunoprophylaxis failure who were infected with hepatitis B virus surface antigen gene mutant.
Hsu HY; Chang MH; Ni YH; Jeng YM; Chiang CL; Chen HL; Wu JF; Chen PJ
J Infect Dis; 2013 Apr; 207(7):1047-57. PubMed ID: 23300165
[TBL] [Abstract][Full Text] [Related]
14. [The discrepancy of HBsAg titre and HBV DNA in patients with chronic hepatitis B, HBV-related liver cirrhosis and hepatocellular carcinoma].
Pei YZ; Han T; Ma XY; Li Y; Xing J; Song ZL
Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):743-6. PubMed ID: 22409845
[TBL] [Abstract][Full Text] [Related]
15. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
[TBL] [Abstract][Full Text] [Related]
16. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load.
Tseng TC; Liu CJ; Yang HC; Su TH; Wang CC; Chen CL; Kuo SF; Liu CH; Chen PJ; Chen DS; Kao JH
Gastroenterology; 2012 May; 142(5):1140-1149.e3; quiz e13-4. PubMed ID: 22333950
[TBL] [Abstract][Full Text] [Related]
17. Transplantation of hepatitis B surface antigen-positive livers into hepatitis B virus-positive recipients and the role of hepatitis delta coinfection.
Franchello A; Ghisetti V; Marzano A; Romagnoli R; Salizzoni M
Liver Transpl; 2005 Aug; 11(8):922-8. PubMed ID: 16035057
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of genotype D in chronic liver disease patients with occult HBV infection in northern region of India.
Rizvi M; Azam M; Sultan A; Shukla I; Malik A; Ajmal MR; Khan F; Sami H
Indian J Pathol Microbiol; 2014; 57(4):537-41. PubMed ID: 25308003
[TBL] [Abstract][Full Text] [Related]
19. T cell responses and viral variability in blood donation candidates with occult hepatitis B infection.
Bes M; Vargas V; Piron M; Casamitjana N; Esteban JI; Vilanova N; Pinacho A; Quer J; Puig L; Guardia J; Sauleda S
J Hepatol; 2012 Apr; 56(4):765-74. PubMed ID: 22173156
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of occult hepatitis B virus infection among hepatopathy patients and healthy people in China.
Fang Y; Shang QL; Liu JY; Li D; Xu WZ; Teng X; Zhao HW; Fu LJ; Zhang FM; Gu HX
J Infect; 2009 May; 58(5):383-8. PubMed ID: 19329189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
